Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score

PurposeBreast MRI background parenchymal enhancement (BPE) can potentially serve as a prognostic marker, by possible correlation with molecular subtype. Oncotype Dx, a gene assay, is a prognostic and predictive surrogate for tumor aggressiveness and treatment response. The purpose of this study was...

Full description

Bibliographic Details
Main Authors: Michelle Zhang, Meredith Sadinski, Dana Haddad, Min Sun Bae, Danny Martinez, Elizabeth A. Morris, Peter Gibbs, Elizabeth J. Sutton
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
breast cancer
magnetic resonance imaging
oncotype
risk score
background parenchymal enhancement
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.595820/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.595820/full

Similar Items